J&J Says Teva Will Infringe UK Schizophrenia Drug Patent
Janssen Pharmaceuticals is seeking to block generic-drug giant Teva from producing its own treatment for schizophrenia in the U.K. in its ongoing battle with the Israeli company....To view the full article, register now.
Already a subscriber? Click here to view full article